{"name":"German Heart Center","slug":"german-heart-center","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"aprotinin or tranexamic acid","genericName":"aprotinin or tranexamic acid","slug":"aprotinin-or-tranexamic-acid","indication":"Surgical bleeding","status":"phase_3"}]}],"pipeline":[{"name":"aprotinin or tranexamic acid","genericName":"aprotinin or tranexamic acid","slug":"aprotinin-or-tranexamic-acid","phase":"phase_3","mechanism":"Tranexamic acid works by inhibiting the activation of plasminogen to plasmin, thereby reducing fibrinolysis and preventing excessive bleeding.","indications":["Surgical bleeding","Menorrhagia"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQRF9VWEVfYzJMNDZ2ckowMmhVR1FubFFNcHlubkFwUkVmSVdpd0JUbzVEWjZmSFZEMkNMRmp6RXFiUHJHdjFXcHRhdWJsQlphZDlWQ19jMms5YVZUYXItR1Z2OGFhNTU1ZjZpZnBxM0lYMXZxTVJqVjFaa0RMb3k0NW13VGkxVUtvTGhiUmdubUR1dGJIMEtCSHdqaTVuTUM2U3dYMm03Q1J6Vkd4SVNMMk0zbw?oc=5","date":"2026-02-17","type":"pipeline","source":"Fierce Pharma","summary":"Stada earmarks €85M to build out Middle East production hub in Saudi Arabia - Fierce Pharma","headline":"Stada earmarks €85M to build out Middle East production hub in Saudi Arabia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE1rS1NiekNxUmZRVHN2UWZfdElCYXlyS01uTDM3TTJ1T1dEaFhKYVluQ29BWF8zVWtGckM5bm04N1JYZFJpN3B2amZ5dUNCQVJpdVZaVDA1QmtQazdWaHRaNGh6UUZTX3ZDUGk2aDctaw?oc=5","date":"2025-11-12","type":"trial","source":"ScienceDaily","summary":"New study finds Ozempic and Mounjaro protect the heart too - ScienceDaily","headline":"New study finds Ozempic and Mounjaro protect the heart too","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE9nOERSbWNZVzhOalFHVENtUFlfNUE3MElaT3RRdjRkWkdjUEx6ZDNIM0U3bEg3UEh4X0hiX000QXhHSWI4R2Rac2ZvcXBKZUNVbVpuSDUzTDBlU1J1QnZtUkRJYTBuTUlKbXZN?oc=5","date":"2025-09-19","type":"pipeline","source":"Wiley Online Library","summary":"SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI - Wiley Online Library","headline":"SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE1FaHBXdzBwcno2SzVHdzdhenZSU3MtMzNfa0FTU1l2NEdCUjFuQ052aTd6aWg1aVVhYTFTRmdYczl4YnJjMjllNkhhR3pLeXRyYm1RUnFpZm00a1l6ZGZWUHVOWnIxejFNWVc0?oc=5","date":"2025-09-14","type":"pipeline","source":"Wiley Online Library","summary":"Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MI - Wiley Online Library","headline":"Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1TVUFXVjdmcHhJZWpsRmwzMVJjdjJ2TjNiZ1RJX3ktZjhWSEZPRml3amlCU2NwYTN3NHhiVy05Ri1xQnV6Tm9SXzZpSC1sX20ySXZQUlZ4NllIVUxBWmhj?oc=5","date":"2025-06-13","type":"trial","source":"nature.com","summary":"Secondary analysis of the EMPACT-MI trial reveals cardiovascular–kidney efficacy and safety of empagliflozin after acute myocardial infarction - nature.com","headline":"Secondary analysis of the EMPACT-MI trial reveals cardiovascular–kidney efficacy and safety of empagliflozin after acute","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQWWJ5bVFTaDk5NXJnNEJaRE1ZSlVDSXJCYzM5UUR2UlZYWTh1dF9XM3FvdEhKZVJUeEFnZFVFMEZOa2dianZQUjNjQVBvLVdnZWtpZnptYWh0ZkdHZU1mRHZvT2lsVkk5WkJ3TGdpUmNjb1NxeVhVdHdnc3lTVllCRXpoekIxVXFTRzBiWnpKRnVlRTBlaTJLenQ4R0pMdw?oc=5","date":"2025-06-11","type":"trial","source":"Medscape","summary":"Study Shows Safety of Pharma-Grade CBD for Myocarditis - Medscape","headline":"Study Shows Safety of Pharma-Grade CBD for Myocarditis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE9IZTJOZFhQYTBrRTdvTXlBUXlBVDN2V0xIOTkzRkVPSWFJdkRSM1I3bEJINkJqWjN2ZFAwM2tfbUNOcjcyMm9tY3haY05QdEFvY3RnR2VERXVOQnlKTWI3QlNzX2M0QTNZMm44?oc=5","date":"2025-05-04","type":"pipeline","source":"Wiley Online Library","summary":"Novel three‐dimensional ECG algorithm for reliable screening for cardiac amyloidosis - Wiley Online Library","headline":"Novel three‐dimensional ECG algorithm for reliable screening for cardiac amyloidosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE9JaHFNNFNRZ1RZYnJfUC1nZVZiSy1iWF9yeF9oTkNwdUQ0Um9NQ1RtTm4tNWk2ZnI3UTZKV1lVdmJUX0NPYnhRbVJBRF83RUNwZmRPbU5KV3MxQWtwYk9vclBjQlVSWWpFZTFr?oc=5","date":"2024-09-03","type":"pipeline","source":"Wiley Online Library","summary":"Finerenone and left ventricular hypertrophy in chronic kidney disease and type 2 diabetes - Wiley Online Library","headline":"Finerenone and left ventricular hypertrophy in chronic kidney disease and type 2 diabetes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPZjRpUjl5Z0txaWN0MV8wSDNxNDJtc3Zjb2E1LTg4a2lDcDVQRDhqaDh1NzlMQy1uWjh3UUwtZDR4b2RyeU40Mi1iVUhnWnVxUEttTWNKUFA3d0Q4V1RUMHpYZTBCLXFOUE56R0NsM0E3dEFGRElRc1EtcUJ3QTFDdHNyTHNQZWtydTZKMFVnS2tJSS1zV1NNdjJfZVhjdXFW?oc=5","date":"2024-06-26","type":"pipeline","source":"Frontiers","summary":"Brief Research Report: Quantitative Analysis of Potential Coronary Microvascular Disease in Suspected Long-COVID Syndrome - Frontiers","headline":"Brief Research Report: Quantitative Analysis of Potential Coronary Microvascular Disease in Suspected Long-COVID Syndrom","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE52MGI2ZmpvZkI4dzNLdjJnRzVjdElaemZFaE8xZkZmTnd4ZFIzMC1YLWVvTlRxZ2NHNi1UbGRweFRZaUZSenlfcGtZbGFSak55ejdGTzZ0dGp0bjFmbnB3?oc=5","date":"2022-04-20","type":"pipeline","source":"nature.com","summary":"Publisher Correction: Extensive identification of genes involved in congenital and structural heart disorders and cardiomyopathy - nature.com","headline":"Publisher Correction: Extensive identification of genes involved in congenital and structural heart disorders and cardio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5lV3I0ZzZOcnltMV83QWc4STVsY21xa1g5cExVcERLZW4wbWtMVHhTcXpsVkVEVWt5YUdleThLbHRGa0xEZ0RQQVJTdGZmUDQzLVZuaEJRcVJGQ0hKd1Rj?oc=5","date":"2022-02-28","type":"trial","source":"nature.com","summary":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial - nature.com","headline":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1DWXotM3BHRWZsSjdzNHNpTXhaekQyNnkxaFBmdDYtUXF0U0dfQjFXU21xZzlYeDBjaGg0VWJhVW5QVG4tcnpGczlOM1Vqb1RTRkt5aGtMRlRXbnM5ZzBN?oc=5","date":"2022-02-17","type":"pipeline","source":"nature.com","summary":"Extensive identification of genes involved in congenital and structural heart disorders and cardiomyopathy - nature.com","headline":"Extensive identification of genes involved in congenital and structural heart disorders and cardiomyopathy","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}